D.Western Therapeutics Institute, Inc.
4576Growth MarketPharmaceuticals
3rd Quarter of FY2026/12Earnings Release
3Q results: losses held flat YoY despite a steep revenue decline, as R&D spending was curtailed. The TissueBlue contract extension and K-321 data analysis are the next focal points.
November 12, 2026 at 17:10 GMT+9